Search

everythinglearnresearchcommunity

for

Search:↓

The number of advanced breast cancer cases in women under 40 has increased, but the overall numbers are still low.

PCOS may increase the risk of certain cancers.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

The paper concludes that breast cancer treatment involves complex interactions between medical symptoms, patient experiences, and commercial influences, requiring a holistic approach.

Physical activity, height, and smoking affect prostate cancer risk.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Certain hair straighteners and dyes may increase ovarian cancer risk, especially in African American/Black women.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Onions may help reduce cancer risk and obesity-related issues.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Honey and bee pollen can help reduce menopausal symptoms in breast cancer patients.

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Finasteride treats hair loss and reduces prostate cancer risk.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

PKC ε increases hair follicle stem cell turnover and may raise skin cancer risk.

A 50-year-old woman with breast cancer developed an autoimmune skin disorder, highlighting the need for thorough checks and team-based treatment.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Olive oil compounds may help prevent cancer in animals, but human results are mixed.

Higher DHT in male baldness may protect against prostate cancer.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.